XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Balance at period start (shares) at Dec. 31, 2021   31,299        
Balance at period start at Dec. 31, 2021 $ 785,435 $ 313 $ 396,771 $ 496,605 $ (54,203) $ (54,051)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued under employee plans 6,252   2,232     4,020
Stock-based compensation 4,463   4,463      
Dividends on common stock ($0.20 per share) (5,899)     (5,899)    
Comprehensive income:            
Cash flow hedging gain, net         1,082  
Pension liability, net of income tax         521  
Foreign currency translation adjustments         (163)  
Net income (loss)       14,975    
Comprehensive income (loss) $ 16,415          
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06          
Balance at period end (shares) at Mar. 31, 2022   31,299        
Balance at period end at Mar. 31, 2022 $ 789,546 $ 313 365,555 526,472 (52,763) (50,031)
Balance at period end (Accounting Standards Update 2020-06) at Mar. 31, 2022 [1] (17,120)   (37,911) 20,791    
Balance at period start (shares) at Dec. 31, 2021   31,299        
Balance at period start at Dec. 31, 2021 785,435 $ 313 396,771 496,605 (54,203) (54,051)
Comprehensive income:            
Cash flow hedging gain, net 5,744          
Pension liability, net of income tax 1,012          
Foreign currency translation adjustments (9,661)          
Net income (loss) (153,316)          
Comprehensive income (loss) (156,221)          
Balance at period end (shares) at Jun. 30, 2022   31,299        
Balance at period end at Jun. 30, 2022 672,968 $ 313 401,182 352,089 (57,108) (23,508)
Balance at period start (shares) at Mar. 31, 2022   31,299        
Balance at period start at Mar. 31, 2022 789,546 $ 313 365,555 526,472 (52,763) (50,031)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued under employee plans 1,244   611     633
Stock-based compensation 5,755   5,755      
Dividends on common stock ($0.20 per share) (6,092)     (6,092)    
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (25,890)     25,890
Adjustments to Additional Paid in Capital, Convertible Note Premium on Extinguishment 103,125   103,125      
Adjustments to Additional Paid in Capital, Settlement of Convertible Notes Hedge Transactions 118,912   118,912      
Adjustments to Additional Paid in Capital, Warrant Settled (96,758)   (96,758)      
Adjustments to Additional Paid in Capital, Convertible Note Hedge, Net of Income Tax (142,128)   (142,128)      
Issuance of warrants 72,000   72,000      
Comprehensive income:            
Cash flow hedging gain, net 4,662       4,662  
Pension liability, net of income tax 490       490  
Foreign currency translation adjustments (9,497)       (9,497)  
Net income (loss) (168,291)     (168,291)    
Comprehensive income (loss) (172,636)          
Balance at period end (shares) at Jun. 30, 2022   31,299        
Balance at period end at Jun. 30, 2022 672,968 $ 313 401,182 352,089 (57,108) (23,508)
Balance at period start (shares) at Dec. 31, 2022   31,299        
Balance at period start at Dec. 31, 2022 745,545 $ 313 413,235 412,631 (57,858) (22,776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued under employee plans 2,600   556     2,044
Stock-based compensation 5,726   5,726      
Dividends on common stock ($0.20 per share) (6,113)     (6,113)    
Comprehensive income:            
Cash flow hedging gain, net         877  
Pension liability, net of income tax         403  
Foreign currency translation adjustments         1,596  
Net income (loss)       1,819    
Comprehensive income (loss) 4,695          
Balance at period end (shares) at Mar. 31, 2023   31,299        
Balance at period end at Mar. 31, 2023 752,453 $ 313 419,517 408,337 (54,982) (20,732)
Balance at period start (shares) at Dec. 31, 2022   31,299        
Balance at period start at Dec. 31, 2022 745,545 $ 313 413,235 412,631 (57,858) (22,776)
Comprehensive income:            
Cash flow hedging gain, net 1,381          
Pension liability, net of income tax 806          
Foreign currency translation adjustments 2,724          
Net income (loss) 15,551          
Comprehensive income (loss) 20,462          
Balance at period end (shares) at Jun. 30, 2023   31,299        
Balance at period end at Jun. 30, 2023 780,194 $ 313 432,780 415,924 (52,947) (15,876)
Balance at period start (shares) at Mar. 31, 2023   31,299        
Balance at period start at Mar. 31, 2023 752,453 $ 313 419,517 408,337 (54,982) (20,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued under employee plans 11,697   6,841     4,856
Stock-based compensation 6,422   6,422      
Dividends on common stock ($0.20 per share) (6,145)     (6,145)    
Comprehensive income:            
Cash flow hedging gain, net 503       503  
Pension liability, net of income tax 403       403  
Foreign currency translation adjustments 1,129       1,129  
Net income (loss) 13,732     13,732    
Comprehensive income (loss) 15,767          
Balance at period end (shares) at Jun. 30, 2023   31,299        
Balance at period end at Jun. 30, 2023 $ 780,194 $ 313 $ 432,780 $ 415,924 $ (52,947) $ (15,876)
[1] (1)We recorded the cumulative impact of adopting Accounting Standards Update (ASU) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity in 2022.